0000898432-01-500360.txt : 20011018
0000898432-01-500360.hdr.sgml : 20011018
ACCESSION NUMBER: 0000898432-01-500360
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20010930
FILED AS OF DATE: 20011010
COMPANY DATA:
COMPANY CONFORMED NAME: BONMATI REYNALD G
CENTRAL INDEX KEY: 0001006017
STANDARD INDUSTRIAL CLASSIFICATION: []
DIRECTOR
FILING VALUES:
FORM TYPE: 4
BUSINESS ADDRESS:
STREET 1: PREMIUM POINT
CITY: NEW ROCHELLE
STATE: NY
ZIP: 10801
MAIL ADDRESS:
STREET 1: PREMIUM POINT
CITY: NEW ROCHELLE
STATE: NY
ZIP: 10801
SUBJECT COMPANY:
COMPANY DATA:
COMPANY CONFORMED NAME: NORLAND MEDICAL SYSTEMS INC
CENTRAL INDEX KEY: 0000946428
STANDARD INDUSTRIAL CLASSIFICATION: LABORATORY ANALYTICAL INSTRUMENTS [3826]
IRS NUMBER: 061387931
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-26206
FILM NUMBER: 1756283
BUSINESS ADDRESS:
STREET 1: 106 CORPORATE PARK DRIVE
STREET 2: SUITE 106
CITY: WHITE PLAINS
STATE: NY
ZIP: 10604
BUSINESS PHONE: 9146942285
MAIL ADDRESS:
STREET 1: 106 CORPORATE PARK DRIVE
STREET 2: SUITE 106
CITY: WHITE PLAINS
STATE: NY
ZIP: 10604
FORMER COMPANY:
FORMER CONFORMED NAME: OSTECH INC
DATE OF NAME CHANGE: 19950608
4
1
norland_form4.txt
------------------- UNITED STATES SECURITIES AND EXCHANGE COMMISSION -------------------------
FORM 4 Washington, D.C. 20549 OMB APPROVAL
------------------- -------------------------
/ / Check this box if no longer STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OMB Number: 3235-0287
subject to Section 16. Form Expires:December 31, 2001
4 or Form 5 obligations may Filed pursuant to Section 16(a) of the Securities Exchange Act of Estimated average burden
continue. 1934, Section 17(a) of the Public Utility Holding Company Act of hours per response....0.5
SEE Instruction 1(b) 1935 or Section 30(f) of the Investment Company Act of 1940
(Print or Type Response)
------------------------------------------------------------------------------------------------------------------------------------
1. Name and Address of Reporting Person* 2. Issuer Name and Ticker or Trading Symbol 6. Relationship of Reporting
Person(s) to Issuer
Bonmati Reynald G. Norland Medical Systems, Inc. (NRLD) (Check all applicable)
-----------------------------------------------------------------------------------------------------
(Last) (First) (Middle) 3. IRS or Social Security 4. Statement for Month/Year X Director X 10% Owner
Number of Reporting September, 2001 --- ---
Person (Voluntary) X Officer --- Other
---(give title (specify
Premium Point below) below)
President & Chairman
--------------------------------------------- -------------------------------------------------------
(Street) 5. If Amendment, Date of 7. Individual or Joint/Group
Original (Month/Year) Filing (Check Applicable
Line)
New Rochelle NY 10801-5328 X Form filed by One
--- Reporting Person
--- Form filed by More than
One Reporting Person
------------------------------------------------------------------------------------------------------------------------------------
(City) (State) (Zip) Table 1 - Non-Derivative Securities Acquired, Disposed of,
or Beneficially Owned
------------------------------------------------------------------------------------------------------------------------------------
1. Title of Security 2. Trans- 3. Transaction 4. Securities Acquired (A) 5. Amount of 6. Ownership 7. Nature of
(Instr. 3) action Date Code or Disposed of (D) Securities Form: Indirect
(Instr. 8) (Instr. 3, 4 and 5) Beneficially Direct Beneficial
Owned at End (D) or Ownership
of Month Indirect
(Instr. 3 (I)
(Month/Day/ --------------------------------------------- and 4) (Instr. 4) (Instr. 4)
Year) Code V Amount (A) or (D) Price
------------------------------------------------------------------------------------------------------------------------------------
Common Stock, par value $.0005 9/21/01 J 87,842 D $.08 0 I See note (1)
per share
------------------------------------------------------------------------------------------------------------------------------------
Common Stock, par value $.0005
per share 11,831,916 I See note (2)
------------------------------------------------------------------------------------------------------------------------------------
Common Stock, par value $.0005
per share 9/21/01 J 17,568 A $0.08 1,081,878 I See note (3)
------------------------------------------------------------------------------------------------------------------------------------
Common Stock, par value $.0005
per share 9/21/01 J 70,274 A $0.08 D
------------------------------------------------------------------------------------------------------------------------------------
Common Stock, par value $.0005
per share 9/21/01 S 200,000 D $0.08 4,000,230 D
------------------------------------------------------------------------------------------------------------------------------------
------------------------------------------------------------------------------------------------------------------------------------
------------------------------------------------------------------------------------------------------------------------------------
------------------------------------------------------------------------------------------------------------------------------------
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly. SEC 1474 (3-99)
*If the form is filed by more than one reporting person, see Instruction 4(b)(v). Page 1 of 3
(Print or Type Response)
FORM 4 (continued) TABLE II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(E.G., puts, calls, warrants, options, convertible securities)
------------------------------------------------------------------------------------------------------------------------------------
1. Title of Derivative 2. Conversion or 3. Transaction 4. Transaction 5. Number of Derivative 6. Date Exercisable
Security (Instr. 3) Exercise Price Date Code Securities Acquired (A) and Expiration Date
of Derivative Instr. 8) or Disposed of (D)
Security (Month/Day/ (Instr. 3, 4 and 5) (Month/ Day/Year)
Year)
----------------------------------------------------------------------
Code V (A) (D) Date Exercisable
------------------------------------------------------------------------------------------------------------------------------------
------------------------------------------------------------------------------------------------------------------------------------
------------------------------------------------------------------------------------------------------------------------------------
------------------------------------------------------------------------------------------------------------------------------------
------------------------------------------------------------------------------------------------------------------------------------
Explanation of Responses:
/s/Marian E. Gustafson October 10, 2001
------------------------------- -------------------
**Signature of Reporting Person Date
BY: MARIAN E. GUSTAFSON
FOR: REYNALD G. BONMATI
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations.
** Signature of Reporting Person
SEE 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient,
SEE Instruction 6 for procedure.
SEE Instruction 6 for procedure. Page 2 of 3
FORM 4 (continued) TABLE II(a) - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(E.G., puts, calls, warrants, options, convertible securities)
------------------------------------------------------------------------------------------------------------------------------------
7. Title and Amount of 8. Price of Derivative Security 9. Number of derivative 10. Ownership Form of 11. Nature of
Underlying Securities (Instr. 5) Securities Beneficially Derivative Security: Indirect
(Instr. 3 and 4) Owned at End of Month Direct (D) or Beneficial
(Instr. 4) Indirect (I) Ownership
(Instr. 4) (Instr. 4)
Amount
or
Number
Title of Shares
------------------------------------------------------------------------------------------------------------------------------------
------------------------------------------------------------------------------------------------------------------------------------
------------------------------------------------------------------------------------------------------------------------------------
------------------------------------------------------------------------------------------------------------------------------------
------------------------------------------------------------------------------------------------------------------------------------
Explanation of Responses:
/s/Marian E. Gustafson October 10, 2001
------------------------------- -------------------
**Signature of Reporting Person Date
BY: MARIAN E. GUSTAFSON
FOR: REYNALD G. BONMATI
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations.
** Signature of Reporting Person
SEE 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient,
SEE Instruction 6 for procedure.
SEE Instruction 6 for procedure. Page 2a of 3
NOTES TO FORM 4 FILED BY REYNALD G. BONMATI:
(1) On September 21, 2001, Novatech Resource Corporation distributed all of its 87,842 outstanding shares pro rata to its
stockholders. Mr. Bonmati acquired 70,274 shares. Mr. Bonmati's wife acquired 17,568 shares as trustee of two trusts
benefiting their children (See note (3)).
(2) The amount of securities beneficially owned at the end of the month by the reporting person represents the aggregate number of
shares indirectly owned by the reporting person. This amount represents 11,831,916 shares of the Issuer's common stock held by
Bones, L.L.C., of which the reporting person is a managing member. The aggregate number of shares is reported under the SEC
rules and staff interpretations, although the number includes shares in which the reporting person does not have a pecuniary
interest.
(3) The reporting person disclaims beneficial ownership of the securities except to the extent of his pecuniary interest therein.
In filing this Form 4 and reporting the information contained herein, the undersigned is not admitting to or conceding
beneficial ownership of any securities or rights described herein pursuant to Sections 13 or 16 of the Securities Exchange Act
of 1934, as amended, or any rule or regulation promulgated thereunder. The ownership figure represents shares owned by the
reporting person's wife, as trustee of two trusts benefiting their children, the Sandrine Bonmati Trust and the Chrystele
Bonmati Trust with respect to which the reporting person disclaims beneficial ownership. The Sandrine Bonmati Trust held a
total of 531,600 shares of the issuer's common stock on September 21, 2001. The Chrystele Bonmati Trust held 550,278 shares on
September 21, 2001.